Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Non-receptor type, proline-rich protein tyrosine kinase 2 (Pyk2) is a possible therapeutic target for Kawasaki disease.
Clin Immunol. 2017 Jun;179:17-24. doi: 10.1016/j.clim.2017.01.013. Epub 2017 Feb 3.
Clin Immunol. 2017.
PMID: 28167306
Utility of whole-blood aggregometry for evaluating anti-platelet therapy for Kawasaki disease.
Suzuki C, Yahata T, Okamoto-Hamaoka A, Fujii M, Yoshioka A, Niwa Y, Ikeda K, Nakamura A, Hamaoka K.
Suzuki C, et al. Among authors: okamoto hamaoka a.
Pediatr Int. 2013 Oct;55(5):550-4. doi: 10.1111/ped.12120. Epub 2013 Jul 30.
Pediatr Int. 2013.
PMID: 23659651
Item in Clipboard
Cite
Cite